NAD+ peptides vs oral supplements (NMN, NR) Oral NAD+ precursors (NMN, Nicotinamide Riboside): Precursors that convert to NAD+ 5-30% bioavailability (highly variable) Modest NAD+ increases (20-40%) Very affordable ($30-60/month) Convenient (oral pills) No injection skill needed NAD+ peptides (MOTS-c, etc.): Direct mitochondrial support High bioavailability (80-95%) Significant NAD+ pathway enhancement (50-100%+) Moderate cost ($80-150/month) Requires injection More effective overall Winner : NAD+ peptides for effectiveness, oral supplements for convenience/cost Best approach : Combine both (oral daily + peptide 2x weekly) NAD+ peptides vs NAD+ IV therapy NAD+ IV therapy : Direct NAD+ infusion (250-500mg) Immediate high blood levels Effects last 3-7 days Requires clinic visit (1-3 hours) Very expensive ($300-800 per session) Can cause severe flushing/discomfort NAD+ peptides : Stimulates endogenous production Sustained elevation over days Self-administered (10 minutes) Much more affordable ($20-40 per injection) Minimal side effects Cost comparison (per month): IV therapy: $1,200-3,200 (weekly sessions) Peptides: $80-150 (twice weekly) Savings: 90-95% Winner : NAD+ peptides for cost, sustainability, and convenience When IV makes sense : Acute situations (severe fatigue, illness recovery, one-time boost) NAD+ peptides vs growth hormone peptides Different but complementary approaches to anti-aging and performance Growth hormone peptides (Ipamorelin/CJC-1295): Boost GH and IGF-1 Muscle growth, fat loss Recovery enhancement Body composition focus NAD+ peptides : Boost cellular energy Mitochondrial optimization Metabolic health Energy and longevity focus Can stack : Yes, excellent synergy Combined benefits : Energy + body composition + recovery + anti-aging Read our peptide stacks guide
Mechanism of the Pathogenesis of Glutamate Neurotoxicity in Retinal Ischemia
This pulsatile pattern mirrors natural GH secretion, promoting balanced endocrine signaling
Not all forms of vitamin B12 are suggested to help with nerve pain
The honest caveat: long-term human safety data does not exist
